$CLOQ
CYBERLOQ TECHNOLOGIES, INC. Stock $cloq

$cloq Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223016526 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue		$993.00	$300.00
YoY Change		231.0%	0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.782K	$3.548K	$275.0K
YoY Change	-33.46%	-98.71%	203.26%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$0.00
YoY Change
% of Gross Profit
Operating Expenses	$93.47K	$97.71K	$0.00
YoY Change	-50.95%		-100.0%
Operating Profit	-$93.47K	-$96.71K	-$275.9K
YoY Change	-50.66%	-64.95%
Interest Expense	-$120.3K	-$59.80K	-$8.920K
YoY Change	106.07%	570.4%	72.53%
% of Operating Profit
Other Income/Expense, Net	-$120.3K	-$59.80K	-$27.01K
YoY Change	-26.38%	121.43%
Pretax Income	-$213.7K	-$156.5K	-$302.9K
YoY Change	-39.42%	-48.33%	195.1%
Income Tax
% Of Pretax Income
Net Earnings	-$213.7K	-$156.5K	-$302.9K
YoY Change	-39.42%	-48.33%	195.09%
Net Earnings / Revenue		-15761.63%	-100973.67%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$3.500K
COMMON SHARES
Basic Shares Outstanding	119.7M shares	119.7M shares
Diluted Shares Outstanding	120.8M shares	119.8M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.36K	$18.67K	$52.62K
YoY Change	38.96%	-64.52%	65.06%
Cash & Equivalents	$23.36K	$18.67K	$52.62K
Short-Term Investments
Other Short-Term Assets	$79.40K	$31.85K	$138.8K
YoY Change	301.42%	-77.05%	19725.71%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$102.8K	$50.51K	$191.4K
YoY Change	180.79%	-73.61%	487.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$589.9K	$451.9K
YoY Change	331.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$589.9K	$451.9K	$109.9K
YoY Change	331.84%	311.27%
TOTAL ASSETS
Total Short-Term Assets	$102.8K	$50.51K	$191.4K
Total Long-Term Assets	$589.9K	$451.9K	$109.9K
Total Assets	$692.7K	$502.5K	$301.3K
YoY Change	299.92%	66.77%	824.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.67K	$41.04K	$80.05K
YoY Change	-60.19%	-48.73%	-12.75%
Accrued Expenses	$77.20K	$59.07K	$32.84K
YoY Change	97.85%	79.87%	206.92%
Deferred Revenue	$0.00	$0.00
YoY Change
Short-Term Debt	$185.0K	$185.0K	$220.0K
YoY Change	0.0%	-15.91%	18.92%
Long-Term Debt Due	$162.0K	$60.01K	$1.390K
YoY Change	7649.28%	4217.27%
Total Short-Term Liabilities	$448.8K	$345.1K	$661.0K
YoY Change	-26.99%	-47.78%	129.94%
LONG-TERM LIABILITIES
Long-Term Debt	$30.36K	$30.36K	$107.5K
YoY Change	-62.63%	-71.75%	201.85%
Other Long-Term Liabilities			$163.3K
YoY Change
Total Long-Term Liabilities	$30.36K	$30.36K	$270.8K
YoY Change	-87.59%	-88.79%	660.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$448.8K	$345.1K	$661.0K
Total Long-Term Liabilities	$30.36K	$30.36K	$270.8K
Total Liabilities	$479.2K	$375.5K	$931.7K
YoY Change	-44.24%	-59.7%	188.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.603M	-$7.390M
YoY Change	10.04%
Common Stock	$120.9K	$120.2K
YoY Change	23.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$50.00K	$50.00K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$213.5K	$127.0K	-$630.5K
YoY Change
Total Liabilities & Shareholders Equity	$692.7K	$502.5K	$301.3K
YoY Change	299.92%	66.77%	824.77%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$213.7K	-$156.5K	-$302.9K
YoY Change	-39.42%	-48.33%	195.09%
Depreciation, Depletion And Amortization			$0.00
YoY Change
Cash From Operating Activities	-$157.6K	-$90.70K	-$88.59K
YoY Change	77.98%	2.38%	-17.87%
INVESTING ACTIVITIES
Capital Expenditures	$138.0K	$168.7K	-$109.9K
YoY Change	-616.43%	-253.52%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$138.0K	-$168.7K	-$109.9K
YoY Change	416.43%	53.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	300.3K	$274.0K	196.8K
YoY Change	277.91%	39.23%	74.16%
NET CHANGE
Cash From Operating Activities	-157.6K	-$90.70K	-88.59K
Cash From Investing Activities	-138.0K	-$168.7K	-109.9K
Cash From Financing Activities	300.3K	$274.0K	196.8K
Net Change In Cash	4.690K	$14.60K	-1.680K
YoY Change	-113.1%	-969.05%
FREE CASH FLOW
Cash From Operating Activities	-$157.6K	-$90.70K	-$88.59K
Capital Expenditures	$138.0K	$168.7K	-$109.9K
Free Cash Flow	-$295.6K	-$259.4K	$21.30K
YoY Change	378.18%	-1317.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001437517
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ServiceMember
CY2022Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ServiceMember
CY2023Q1	CLOQ	Loss On Settlement With Officer LossOnSettlementWithOfficer		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q1	CLOQ	Loss On Settlement With Officer And Director LossOnSettlementWithOfficerAndDirector		usd
CY2023Q1	CLOQ	Proceeds From Issuance Of Commonstock To Be Issued ProceedsFromIssuanceOfCommonstockToBeIssued		usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	CLOQ	Beneficial Conversion Feature BeneficialConversionFeature		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1		usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2023Q1	CLOQ	Accumulated Impairment Expense AccumulatedImpairmentExpense		usd
CY2022Q4	CLOQ	Accumulated Impairment Expense AccumulatedImpairmentExpense		usd
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	333-170132
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CYBERLOQ TECHNOLOGIES, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity File Number EntityFileNumber	333-170132
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2118480
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4837 Swift Road
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210-1
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Sarasota
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34231
CY2023Q1	dei	City Area Code CityAreaCode	612
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	961-4536
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	CLOQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	119689754	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18667	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4067	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	31845	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	53811	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	50512	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	57878	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	451940	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	283240	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	451940	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	283240	usd
CY2023Q1	us-gaap	Assets Assets	502452	usd
CY2022Q4	us-gaap	Assets Assets	341118	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	41038	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56322	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	59066	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	47737	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	150000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	150000	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	57925	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2623	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	2088	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	2088	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	345117	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	293770	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	30362	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	30362	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	30362	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	30362	usd
CY2023Q1	us-gaap	Liabilities Liabilities	375479	usd
CY2022Q4	us-gaap	Liabilities Liabilities	324132	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120189754	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120189754	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	119089754	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	119089754	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	120190	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	119090	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	20	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	20	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	50000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	50000	usd
CY2023Q1	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	2450000	shares
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	2450000	shares
CY2023Q1	CLOQ	Shares To Be Issued SharesToBeIssued	149186	usd
CY2022Q4	CLOQ	Shares To Be Issued SharesToBeIssued	149186	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7297212	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7031812	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7389635	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7233122	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	126973	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16986	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	502452	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	341118	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	993	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	993	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	33819	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	206754	usd
CY2023Q1	us-gaap	Officers Compensation OfficersCompensation	45000	usd
CY2022Q1	us-gaap	Officers Compensation OfficersCompensation	60000	usd
CY2023Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	556	usd
CY2022Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	60	usd
CY2023Q1	CLOQ	Rent Expense RentExpense	2298	usd
CY2022Q1	CLOQ	Rent Expense RentExpense	2188	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3548	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4450	usd
CY2023Q1	us-gaap	Supplies Expense SuppliesExpense	1145	usd
CY2022Q1	us-gaap	Supplies Expense SuppliesExpense	1580	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	11341	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1183	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	97707	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	276215	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-96714	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-275915	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	11997	usd
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8920	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	47802	usd
CY2022Q1	CLOQ	Loss On Settlement With Officer LossOnSettlementWithOfficer	18086	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-59799	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27006	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-156513	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-302921	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	119823087	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	86536549	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-35027	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	97500	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2022Q1	CLOQ	Stock To Be Issued During Period Value StockToBeIssuedDuringPeriodValue	50000	usd
CY2022Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	540000	usd
CY2022Q1	CLOQ	Stock Issued During Period Value Preferred Stock Redeemed For Officers Settlement StockIssuedDuringPeriodValuePreferredStockRedeemedForOfficersSettlement	10	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-302921	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-630458	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	54975	usd
CY2022Q2	CLOQ	Stock Issued During Period Common Stock Issued For Debt StockIssuedDuringPeriodCommonStockIssuedForDebt	140000	usd
CY2022Q2	CLOQ	Stock To Be Issued During Period Value StockToBeIssuedDuringPeriodValue	52186	usd
CY2022Q2	CLOQ	Adjustments To Additional Paid In Capital Stock Retirement Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalStockRetirementOfConvertibleDebt	50000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-352806	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-686103	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	210000	usd
CY2022Q3	CLOQ	Stock To Be Issued During Period Value StockToBeIssuedDuringPeriodValue	50000	usd
CY2022Q3	CLOQ	Stock Issued During Period Common Stock To Be Issued For Officers Fees StockIssuedDuringPeriodCommonStockToBeIssuedForOfficersFees	12000	usd
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-490000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-117829	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-41932	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9600	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	49810	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	145000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	60000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-205492	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16986	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16986	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	222500	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-156513	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-156513	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	126973	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	126973	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-156513	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-302921	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	47802	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	184376	usd
CY2022Q1	CLOQ	Loss On Settlement With Officer And Director LossOnSettlementWithOfficerAndDirector	18086	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-21966	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	12949	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-15284	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	18397	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	11329	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	6421	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-90700	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-88590	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	168700	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	109885	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-168700	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-109885	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	44000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	87500	usd
CY2022Q1	CLOQ	Proceeds From Issuance Of Commonstock To Be Issued ProceedsFromIssuanceOfCommonstockToBeIssued	60000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	700	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	100000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	230000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	274000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	196800	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14600	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1675	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4067	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54295	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18667	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52620	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	668	usd
CY2023Q1	CLOQ	Beneficial Conversion Feature BeneficialConversionFeature	222500	usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	100000	usd
CY2022Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	490000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_z3HvtrHFEYL" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zCyQOdO3wAc5">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the year reported. Actual results may differ from these estimates. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	usd
CY2020	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	321725	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	451940	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	283240	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	14500000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3000000	shares
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	719	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	451940	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7389635	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-156513	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	10000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	10	usd
CY2022Q1	us-gaap	Severance Costs1 SeveranceCosts1	50000	usd
CY2022Q1	CLOQ	Gain Loss On Severance Costs GainLossOnSeveranceCosts	18076	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	500000	shares
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50000	usd
CY2022Q1	us-gaap	Litigation Reserve LitigationReserve	490000	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	500000	shares
CY2022Q1	us-gaap	Treasury Stock Value Acquired Par Value Method TreasuryStockValueAcquiredParValueMethod	50000	usd
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	719	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2023Q1	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent	290000	usd
CY2022Q4	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent	60000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	150000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	150000	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	30000	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	30000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	42500	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	100000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	50000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	20000	usd

Files In Submission

Name	View Source	Status
0001493152-23-016526-index-headers.html	Edgar Link	pending
0001493152-23-016526-index.html	Edgar Link	pending
0001493152-23-016526.txt	Edgar Link	pending
0001493152-23-016526-xbrl.zip	Edgar Link	pending
cloq-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cloq-20230331_cal.xml	Edgar Link	unprocessable
cloq-20230331_pre.xml	Edgar Link	unprocessable
cloq-20230331_def.xml	Edgar Link	unprocessable
cloq-20230331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLOQ
CYBERLOQ TECHNOLOGIES, INC. Stock $cloq

2023 Q2 Form 10-Q Financial Statement

#000149315223016526 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLOQ CYBERLOQ TECHNOLOGIES, INC. Stock $cloq

2023 Q2 Form 10-Q Financial Statement

#000149315223016526 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLOQ
CYBERLOQ TECHNOLOGIES, INC. Stock $cloq